Company Search:
Advanced Search
Sponsored Links
ProPhase Labs Inc Company Snapshot
ProPhase Labs Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares ProPhase Labs Inc with three other companies in this sector in the United States: Glycomimetics Inc (2015 sales of $20.07 million of which 100% was Pharmaceutical), TherapeuticsMD Incorporated ($20.14 million of which 100% was Advertising), and China Pharma Holdings, Inc. ($20.35 million ).

Sales Analysis. ProPhase Labs Inc reported sales of $20.60 million for the year ending December of 2015. This represents a decrease of 6.6% versus 2014, when the company's sales were $22.07 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
ProPhase Labs Inc
  Stock Performance Chart for ProPhase Labs Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 2.03
(Figures in U.S. Dollars)
1 Week 0.4%   13 Weeks 1.3%  
4 Weeks 1.4%   52 Weeks 44.9%  
ProPhase Labs Inc Key Data:
  Ticker: PRPH Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 20,604,000
(Year Ending Jan 2016).
Employees: 55
  Currency: U.S. Dollars Market Cap: 34,644,938
  Fiscal Yr Ends: December Shares Outstanding: 17,080,776
  Share Type: Common Closely Held Shares: 4,301,864
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.